title: Human immunodeficiency virus and pregnancy.
abstract: Management of infection with human immunodeficiency virus (HIV) dramatically improved during the 1990s. The advent of high-performance quantitative HIV assays and highly active anti-retroviral therapy (HAART) were the two most important developments in HIV medicine. As a result, HIV mortality and morbidity have significantly reduced. This improvement in life quality and expectancy through the use of HAART has led to an increase in the number of HIV-infected patients wishing to have children. The mother-to-child transmission which was of major concern previously can now be significantly reduced by newer management strategies. This review stresses on the management of pregnancy in HIV.
authors.affiliation: Department of Obstetrics and Gynaecology, LD Hospital, GMC, Post Box 589, Srinagar, 190001, Jammu and Kashmir, India. reshiparveen@yahoo.com
authors.forename: Parveen
authors.initials: P
authors.lastname: Reshi
authors.forename: Iqbal M
authors.initials: IM
authors.lastname: Lone
mesh_terms: D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D002585:Cesarean Section; D024882:Drug Resistance, Viral; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000635:transmission; D006801:Humans; D007317:Insemination, Artificial, Homologous; D008755:Methylergonovine / Q000627:therapeutic use; D010120:Oxytocics / Q000627:therapeutic use; D006473:Postpartum Hemorrhage / Q000188:drug therapy; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D019562:Viral Load
chemical_list: D044966:Anti-Retroviral Agents; D010120:Oxytocics; D008755:Methylergonovine